Szabina Kádár

发表

Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility

L. Őrfi, E. Borbás, J. Dobos, 2021, Heliyon.

Understanding the pH Dependence of Supersaturation State—A Case Study of Telmisartan

A. Avdeef, A. Farkas, J. Madarász, 2022, Pharmaceutics.

Flux-Based Formulation Development—A Proof of Concept Study

Z. Nagy, A. Farkas, Brigitta Nagy, 2022, The AAPS journal.

Flux-Based Formulation Development—A Proof of Concept Study

Z. Nagy, A. Farkas, Brigitta Nagy, 2022, The AAPS Journal.

The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character

I. Antal, R. Ambrus, E. Balogh, 2023, Pharmaceutics.

Towards more accurate solubility measurements with real time monitoring: a carvedilol case study

H. Pataki, E. Borbás, K. Takács-Novák, 2021, New Journal of Chemistry.

Prediction of bioequivalence and food effect using flux and solubility based methods.

H. Pataki, E. Borbás, K. Takács-Novák, 2019, Molecular pharmaceutics.

Use of an In Vitro Skin Parallel Artificial Membrane Assay (Skin-PAMPA) as a Screening Tool to Compare Transdermal Permeability of Model Compound 4-Phenylethyl-Resorcinol Dissolved in Different Solvents

S. Grégoire, K. Takács-Novák, Szabina Kádár, 2021, Pharmaceutics.

Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes.

I. Sebe, Z. Szabó, G. Tóth, 2024, International journal of pharmaceutics.